Updated Q3 2026 by CT Acquisitions.

Growth equity partner selection for LMM operators: the 2026 playbook

A growth equity partner is the minority institutional investor that writes a $10M to $150M check into an already-profitable, already-scaling lower middle market company in exchange for a 15% to 45% stake, a board seat, and structured downside protection. This guide is written for LMM operators running $3M to $50M in revenue and $1M to $25M in EBITDA who are considering a first non-control round to accelerate a specific growth thesis. It ignores the Silicon Valley Series A pattern, the pre-seed venture playbook, and the retail crowdfunding pitch. It focuses on which growth equity partner firms actually write LMM checks in 2026, what dilution and preferred-return terms are moving, how the process runs from teaser to close, and where the traps live inside the term sheet that read clean on the first pass.

What is a growth equity partner?

A growth equity partner is a minority institutional investor that puts $10M to $150M of primary or secondary capital into a profitable, scaling LMM company in exchange for 15% to 45% ownership, board rights, and preferred-return protection. Named 2026 examples include Summit Partners, TA Associates, and JMI Equity, all of which target profitable, capital-efficient companies with $5M+ ARR or $1M+ EBITDA.

The label “growth equity” sits between venture capital and traditional buyout private equity on the risk-return spectrum. A venture round funds an unprofitable startup burning to acquire users. A traditional PE buyout takes majority control of a mature cash-generating business and levers it with debt. A growth equity partner sits in the middle: the company is already generating cash, product-market fit is demonstrated, and the capital funds a specific expansion (geographic rollout, sales team scale, tuck-in M&A, working capital for a new SKU) rather than survival.

The distinction matters because the term sheet and the diligence process differ. A growth equity partner will not ask for a majority; the founder retains control post-close. But that partner will demand protective consent rights, information rights, a board seat, and a preferred-return structure that guarantees the fund gets its capital back first if the company sells at a lower multiple than expected. According to Bain and Company Global Private Equity Report 2025, growth equity accounted for 22% of global private capital fundraising in 2024, roughly $348 billion in cumulative dry powder, and 2025 deployment ran materially below the 2021 peak as sponsors held out for cleaner data rooms and higher-quality targets.

For an LMM operator, the practical question is not “should I raise growth equity” but “which specific growth equity partner would clear diligence on my business, at what dilution, and against which named alternatives.” That is the question this guide answers. If you want to find the right equity partner for your specific revenue profile and growth thesis, CT Acquisitions runs targeted processes for LMM operators every week.

Who typically uses a growth equity partner?

Growth equity partners write checks into profitable LMM companies with $5M to $100M in revenue, $1M to $25M in EBITDA, and a specific expansion thesis. Typical users are founder-owned or family-owned businesses in software, tech-enabled services, healthcare services, business services, and specialty consumer, aged 8 to 25 years old, with 15%+ organic growth rates and gross margins above 40%.

The audience for growth equity is narrower than the audience for a broker or a debt facility. The company usually has crossed the “default alive” threshold, meaning existing cash flow could sustain the business indefinitely without new capital. That gives the founder the option to raise or not raise, which is the leverage that makes a growth equity round different from a distressed capital raise. In our advisory book at CT, roughly 40% of LMM operators who explore growth equity ultimately choose a full sell-side process or a debt-only refinance instead. That is a healthy screen. Growth equity should be additive, not a rescue.

The 2024-2026 audience skews toward these profiles: a $12M ARR vertical SaaS business that wants to build out an enterprise sales team without diluting founder ownership below 55%; a $30M revenue healthcare services rollup that needs $25M to fund three tuck-ins and a regional platform build; a $45M revenue specialty consumer brand that wants to buy inventory ahead of a national retail launch and take $8M of founder liquidity off the table. In each case, the check is $10M to $40M, the dilution is 20% to 35%, and the fund holds 4 to 7 years before exit.

What growth equity is not: it is not a substitute for a Series A when the company has no profitability, not a substitute for an SBA loan when the check is under $5M, and not a substitute for a full sale when the founder wants to fully exit. For those situations, review business acquisition loan options, the lower middle market M&A advisor guide for full-exit paths, or the m-and-a-advisory pillar for a broader survey of options.

How does a growth equity partner compare to alternatives?

Growth equity sits between venture capital, traditional PE buyouts, mezzanine debt, and unitranche facilities on the capital-stack ladder. Compared to VC, growth equity requires profitability. Compared to PE buyouts, it leaves the founder in control. Compared to mezzanine, it does not carry a fixed coupon or amortization schedule. Named 2025 mezzanine providers include Peninsula Capital Partners and Monroe Capital; growth equity peers include Summit Partners and TA Associates.

The following table maps growth equity against the four main LMM alternatives across the dimensions that matter to a founder: cost of capital, dilution, control, timeline, and exit expectation.

Capital source	Typical check	Cost / return target	Ownership taken	Control impact	Hold period
Growth equity partner (minority)	$10M to $150M	3x to 5x fund MOIC; 20% to 30% target IRR	15% to 45%	Board seat, consent rights, founder stays CEO	4 to 7 years
Venture capital (growth stage)	$5M to $50M	10x fund MOIC target; 30%+ IRR	10% to 25%	Board seat, protective rights, dilution risk	5 to 10 years
PE buyout (control)	$25M to $500M+	2.5x to 3.5x fund MOIC; 20% to 25% IRR	60% to 100%	Board control, potential CEO change	3 to 6 years
Mezzanine debt	$5M to $75M	10% to 14% cash coupon + PIK + warrants	0% to 5% via warrants	Board observer, no operational control	5 to 7 year term
Unitranche debt	$25M to $250M	SOFR + 550 to 700 bps	0%	Financial covenants only	5 to 7 year term
Family office equity	$5M to $100M	2x to 3x MOIC over long hold	20% to 100%	Varies widely by family	7 to 20 years

The economics deserve a closer read. On a $50M enterprise-value LMM business, a $15M growth equity check for 30% dilution values the equity at $50M pre-money and $65M post-money. The founder retains 70% of a bigger company, and the fund needs an exit above $250M (roughly 5x growth) over five years to hit its target return. That growth arithmetic drives the diligence: the fund will spend weeks pressure-testing whether the company can plausibly triple or quadruple within the hold period. According to PitchBook 2024 US PE Breakdown, median growth equity entry multiples for LMM deals sat at 9.2x TTM EBITDA in 2024, down from the 11.4x peak in 2021 but well above the 7.8x 2018 baseline.

For a deeper split on the venture versus growth versus PE distinction, read the CT explainer at growth equity vs private equity. For a debt-alternative view, see mezzanine debt for acquisitions guide and unitranche debt acquisition financing.

When does a growth equity partner make sense?

A growth equity partner makes sense when the LMM business has $1M+ EBITDA, 15%+ organic growth, a specific $10M+ growth investment need, and the founder wants to retain majority control with 4 to 7 more years running the company. It makes less sense when EBITDA is below $1M, growth is stalling, the capital need is under $5M, or the founder wants to fully exit within 24 months.

The fit test is more precise than it looks. A growth equity partner will not underwrite a first check into a company where the CEO plans to retire in two years; the fund needs the founder engaged through the value-creation plan. Similarly, a business with declining organic growth cannot absorb growth capital productively, so the round would fund the wrong problem. In the 2024 vintage, roughly 30% of first-round growth equity deals we tracked at CT closed with a founder rollover of at least 20%, signaling both alignment and long-term intent.

Three specific 2024-2026 scenarios illustrate the fit:

1. Vertical SaaS accelerating from $10M to $30M ARR. A $20M primary check funds enterprise sales team buildout, land-and-expand SDR investment, and one adjacent-vertical acquisition. Sponsor targets 3.5x MOIC on the growth capital over five years. Recent comp: PSG’s $50M investment in Semarchy in 2024 per PSG press release.
2. Healthcare services rollup at $8M EBITDA. A $30M check ($20M primary, $10M secondary) funds three regional tuck-ins to reach $18M EBITDA in 24 months, then a full sale in year 4. Typical sponsors: Frontenac, Riverside Company, Peninsula Capital Partners. Recent comp: Frontenac’s 2024 recap of Health Connect America per Frontenac press release.
3. Consumer brand at $40M revenue and $6M EBITDA. A $15M primary check funds retail placement, inventory buildup, and a founder liquidity slice of $5M. Sponsor targets 4x MOIC. Recent comp: L Catterton and Warburg Pincus have both been active in this range in 2024 to 2026.

The counterpoint is when growth equity does not fit. If the founder wants a full exit, run a sell-side process instead through the m-and-a-advisory path. If the business needs $3M for working capital, look at SBA and cash-flow loans instead. Growth equity is expensive capital in dilution terms and only pays back at scale.

How much does a growth equity partner cost?

A 2026 growth equity round costs the LMM founder 15% to 45% ownership plus 3% to 6% in transaction fees (advisor, legal, QoE, tax). The implicit cost of equity is 25% to 35% annualized, since the fund needs 3x to 5x MOIC over 4 to 7 years. Named advisors like Houlihan Lokey, William Blair, and Raymond James typically charge 1% to 3% success fees on LMM deals.

The economics of a growth equity round split into three buckets: dilution, coupon, and transaction expense. Dilution is the largest cost and depends entirely on entry multiple and check size. Coupon (or preferred return) is the compounding dividend that accrues to the fund even before conversion. Transaction expense is the friction cost of running the process.

Cost bucket	Typical range	Who charges it	Timing	Negotiable?
Dilution (equity given up)	15% to 45%	Growth equity partner	At close	Yes, via auction pressure
Preferred coupon (cumulative)	6% to 8% per year	Growth equity partner	Accrues; paid at exit	Partially, via LOI leverage
M&A advisor success fee	1% to 3% of proceeds	Boutique IB or advisor	At close	Yes, tiered scale
Quality of Earnings (QoE)	$75,000 to $200,000	Big 4 or QoE specialist	Pre-launch	Fixed fee, minor
Legal counsel (seller)	$150,000 to $500,000	Corporate M&A firm	LOI through close	Cap negotiable
Tax and structure counsel	$50,000 to $150,000	CPA firm or tax boutique	LOI through close	Fixed fee
R and W insurance (buyer paid, often shared)	2.5% to 4% of limit	Buyer, sometimes 50/50	At close	Yes, sharing
Environmental / IT / regulatory diligence	$25,000 to $100,000	Buyer typically	Confirmatory diligence	N/A

The total friction cost on a $30M round runs $600,000 to $1.8M in absolute fees, or roughly 2% to 6% of gross proceeds per GF Data 2025 M&A benchmarks. That does not include the ongoing cost of the preferred coupon (which accrues silently at 6% to 8% per year until exit) or the opportunity cost of the diluted ownership. A founder who sells 30% at $50M pre-money and the company then sells for $200M five years later gave up $60M of exit proceeds to get $15M of upfront capital. That is a 4x implicit cost of capital, which is why the growth investment thesis must be robust enough to more than double the exit valuation.

For the debt-alternative math, see mezzanine debt for acquisitions guide. Mezzanine at 12% cash plus 2% PIK is often cheaper than growth equity on a total-cost basis if the company can service the coupon comfortably.

Who are the named growth equity partner firms in 2026?

The 2026 LMM growth equity partner universe is roughly 60 institutional funds writing $10M to $150M minority checks. Named leaders by AUM and 2024-2026 deployment include Summit Partners, TA Associates, JMI Equity, Great Hill Partners, Spectrum Equity, Susquehanna Growth Equity, Mainsail Partners, Frontenac, Providence Strategic Growth, and Volition Capital. Each has a distinct sector focus, check size band, and control preference.

Naming real firms is the difference between a page a founder can act on and a page that reads like generic content. The following table lists ten 2026-active LMM growth equity partners with their sector focus, check size, and a recent public deal comp. All firms are current market participants with SEC filings and public press releases; check size ranges reflect typical deals rather than fund minimums.

Firm	Sector focus	Typical check	Fund size (latest)	Notable 2024-2026 investment
Summit Partners	Software, healthcare, consumer, financial services	$25M to $250M	$9B (Fund XI, 2024 per SEC)	Multiple 2024 vertical SaaS growth rounds
TA Associates	Technology, healthcare, financial services, consumer	$70M to $500M	$16.5B (Fund XV, 2024 per PitchBook)	2024 investment in Netsertive per press release
JMI Equity	Vertical B2B software exclusively	$25M to $150M	$6B (Fund XI, 2024 per PitchBook)	Multiple 2024-2025 SaaS rounds in vertical software
Great Hill Partners	Consumer, healthcare, software, financial services	$50M to $500M	$4.65B (Fund VIII, 2023)	2024 growth investment in ZoomInfo Talent per PR
Spectrum Equity	Internet, information, software	$25M to $150M	$1.5B (Fund IX, 2022)	2024 growth investment in AllTrails follow-on
Susquehanna Growth Equity	Software, information services, fintech	$10M to $75M	$1.5B AUM per firm site	2024 minority investment in RangeMe per PR
Mainsail Partners	Bootstrapped B2B software (LMM specialist)	$15M to $75M	$1.25B (Fund VI, 2024)	2024-2025 rollup of bootstrapped SaaS platforms
Frontenac Company	Healthcare, industrial services, food, consumer	$15M to $75M	$385M (Fund XII, 2022)	2024 investment in Health Connect America
Providence Strategic Growth (PSG)	B2B software (mostly)	$25M to $200M	$6B (Fund V, 2022)	2024 investment in Semarchy per PSG press release
Volition Capital	Software, consumer internet, healthcare tech	$10M to $50M	$675M (Fund V, 2023)	2024 growth round in RxLightning per press release

Ten firms is a starting screen, not an exhaustive list. A well-run 2026 growth equity process might contact 40 to 80 potential sponsors, get IOIs from 6 to 15, hold management meetings with 3 to 6, and receive LOIs from 2 to 4. The narrowing happens through advisor curation, not spam. For a family-office-versus-fund comparison on the same profile, read the CT explainer at family office vs PE buyer. For a sell-side alternative to a growth equity minority, read selling to growth equity investor.

How does the growth equity partner process work?

A growth equity partner process runs 4 to 9 months in ten stages: prep, QoE, teaser, CIM launch, IOIs, management meetings, LOI, exclusivity, confirmatory diligence, and close. The compressed timeline requires clean audited financials, a defensible growth model, and a competent M&A advisor coordinating the auction. Skipping stages typically costs 15% to 25% of enterprise value.

The process is more disciplined than a first-time raiser expects. Each stage has a specific deliverable, a specific counterparty, and a specific gate before moving forward. The order matters because sponsors judge management on execution discipline as much as on financial results.

1. Advisor selection and engagement (week 1 to 2). Founder interviews 3 to 5 M&A advisors, checks references, and signs a mutual engagement letter with success fee, tail, and reimbursables. The advisor conflicts-clears the target buyer list.
2. Quality of Earnings and financial cleanup (week 2 to 10). A Big 4 or QoE specialist builds an EBITDA bridge, normalizes owner add-backs, and produces a databook. This is the single most important pre-launch deliverable per Axial 2024 process research.
3. CIM and financial model (week 6 to 10). The advisor drafts a 40 to 80 page confidential information memorandum with market analysis, historical financials, growth thesis, and a 3-year forecast. The model must survive detailed sponsor pressure-testing.
4. Buyer list finalization (week 8 to 10). Founder approves the outreach list of 40 to 80 growth equity partners, family offices, and strategic investors. Advisor NDAs each prospect before sending the CIM.
5. CIM distribution and IOI collection (week 10 to 14). Advisor sends the CIM under NDA, hosts 30-minute calls with interested parties, and collects indications of interest by a defined deadline. Well-run processes get 6 to 12 written IOIs.
6. Management presentation round (week 14 to 18). Top 4 to 8 IOIs invited to a half-day in-person management presentation. Sponsors probe strategy, customer concentration, growth levers, and management depth.
7. LOI negotiation and selection (week 16 to 20). Advisor collects 2 to 4 LOIs with detailed terms, negotiates in parallel, and helps the founder pick a winner. Exclusivity is granted only after LOI is signed.
8. Confirmatory diligence (week 20 to 28). Winning sponsor commissions legal, tax, IT, environmental, HR, and commercial diligence. Founder responds to hundreds of data-room requests through the advisor.
9. Definitive documentation (week 24 to 32). Purchase agreement, shareholder agreement, employment agreements, rollover documents, R and W insurance, financing commitments. Legal counsel on both sides drives the paper.
10. Close and funds flow (week 28 to 36). Escrow funded, wire released, corporate secretary updates, board reconstituted, first 100-day plan launched.

A poorly run process skips or rushes stages 2, 5, and 7. Skipping QoE means the sponsor demands an aggressive purchase price reduction post-LOI. Skipping the IOI collection means only one bidder shows up, and pricing tension collapses. Skipping LOI negotiation means the founder gives away drag rights and consent rights that will bite in year three. For a deeper primer on the term sheet stage, read what is a term sheet.

What paperwork does a growth equity partner require?

A growth equity partner will request a data room of 300 to 800 documents covering three years of audited financials, tax returns, customer contracts, employee agreements, IP registrations, cap tables, board minutes, insurance policies, and material litigation. The virtual data room typically runs 4 to 8 weeks of full-time work to populate. Well-organized data rooms shave 3 to 6 weeks off the total process.

The documentation load surprises first-time raisers. Sponsors do not accept summary answers; they want primary source documents scanned and indexed by category. The following list is the practical data-room outline used in most 2026 LMM growth equity processes:

• Financial: 3 years audited financials, monthly management P&Ls, cash flow statements, working capital analysis, capital expenditure schedule, debt schedule, QoE report, financial model (Excel), budget vs actuals.
• Tax: 3 years federal and state tax returns, any tax notices, transfer pricing memos, R and D credit studies, sales tax nexus analysis, 280G analysis for parachute payments.
• Legal and corporate: Articles of incorporation, bylaws, cap table, stock ledger, board minutes, prior financing docs, options and warrants, subsidiary structure, jurisdictional filings.
• Customer and revenue: Top 20 customer contracts, standard MSA and SOW templates, customer churn analysis, cohort retention data, pipeline reports, CRM extracts.
• HR and personnel: Org chart, employee census, key employment agreements, non-competes, benefits summaries, ERISA compliance, EEO reports.
• IP: Trademark registrations, patent filings, software license inventory, open source usage audit, domain names.
• Real estate and facilities: Lease agreements, environmental reports, insurance certificates, business continuity plan.
• IT and cybersecurity: Architecture diagrams, SOC 2 report, penetration test results, GDPR and CCPA compliance summary, incident history.
• Litigation and regulatory: Litigation history, regulatory correspondence, industry-specific licenses (healthcare, finance, DOD if applicable).

The QoE report deserves special attention. According to PwC US deals research 2024, roughly 43% of LMM growth equity deals have EBITDA revised downward by more than 10% after the sponsor’s confirmatory diligence. A pre-launch seller-side QoE from a credible provider preempts most of that gap by identifying and normalizing add-backs before the sponsor’s team finds them.

What are the tax and legal implications?

A growth equity minority round is typically structured as a preferred stock investment into a C-corporation or a preferred unit issuance into an LLC. Founders in S-corp or LLC structures usually convert to C-corp pre-round. Federal capital gains treatment at 20% applies to any secondary founder liquidity. State taxes add 0% to 13.3%. Section 1202 QSBS exclusion is available up to $10M per shareholder if the C-corp meets specific holding and use tests.

The tax structuring decisions made in the LOI stage are difficult to reverse post-close. Three main decisions carry the largest tax impact.

Entity conversion. Most growth equity funds require investment into a C-corporation because their LP base includes tax-exempt investors that cannot hold pass-through entity interests. If the target is an S-corp or LLC, the founder converts pre-close. The conversion is usually tax-free if structured as a Section 351 exchange or an F reorganization. Founders should model whether pre-conversion S-corp distributions are worth taking before the transaction. The right advisor pairs a corporate M&A lawyer with a transactional tax specialist; naming both is standard practice.

QSBS eligibility. Section 1202 Qualified Small Business Stock allows exclusion of up to $10M or 10x basis (whichever is greater) of federal capital gains on C-corp stock held for 5 years, if the corporation has gross assets under $50M at issuance and operates in a qualified trade or business. For a founder taking $10M of secondary liquidity, QSBS treatment saves up to $2M in federal tax. The 2024 amendment to Section 1202 under the One Big Beautiful Bill Act (OBBBA) expanded the exclusion; see IRS Newsroom for current guidance.

Rollover treatment. If the founder rolls a portion of existing equity into new preferred (a common 20% to 50% rollover in growth equity deals), the rollover portion is typically tax-deferred under Section 351 or Section 368. The cash portion is taxed at long-term capital gains rates if held over one year. This split, deferred vs current, is often the largest tax lever in the entire transaction.

State tax adds a wrinkle. California residents face 13.3% top marginal rates on the current-taxed portion; Texas, Florida, Tennessee, and Nevada residents face 0%. A domicile move made 12 months before close saves real dollars, though states aggressively contest sham changes of residence. For a broader LMM sell-side tax primer, see the CT guide at lower middle market M&A advisor.

What are common growth equity term sheet structures?

A 2026 growth equity partner term sheet would typically feature convertible preferred stock, 1x non-participating liquidation preference, 6% to 8% cumulative preferred coupon, weighted-average anti-dilution, one board seat plus observer, protective consent rights on 8 to 12 major decisions, drag-along and tag-along, and 20% to 50% founder rollover. Participating preferred with a 3x cap is common in more competitive segments; straight non-participating is more founder-friendly.

The term sheet reads short but each clause carries weight. The four terms that most affect founder economics and control are liquidation preference, participation, coupon, and consent rights.

Liquidation preference. 1x non-participating is the current market standard for competitive LMM growth equity rounds. It means the fund gets its capital back first at exit, then converts to common if that produces a better outcome. 1x participating (also called “double dip”) means the fund gets capital back plus its pro rata share of remaining proceeds, which materially reduces founder economics in mid-outcome exits. Participating with a 3x cap is a common compromise.

Preferred coupon. Cumulative preferred coupons of 6% to 8% per year are common in 2026 growth equity deals. The coupon accrues but is not paid in cash; it compounds into the liquidation preference. On a $20M investment with an 8% cumulative coupon over 5 years, the preference at exit grows from $20M to $29.4M before any conversion decision. That $9.4M comes off founder equity before common shares receive a dollar.

Anti-dilution. Weighted-average anti-dilution (broad-based) is standard. Full-ratchet anti-dilution is aggressive and would materially penalize the founder if a later down round happens. Founders should insist on broad-based weighted-average as a hard line.

Consent rights. A growth equity partner typically wants consent rights on: any dividend, any new debt above a threshold, any acquisition or divestiture above a threshold, any change in the CEO or CFO, any change in company purpose or line of business, any amendment to charter documents, any bankruptcy filing, any redemption, and any dilutive issuance. The dollar thresholds on debt and M&A are the most-negotiated items; a $500,000 threshold is too tight, $10M is more workable for most LMM operations.

The remaining terms (registration rights, information rights, drag and tag, ROFR and co-sale) are more standardized. For a term-sheet-specific walkthrough, review what is a term sheet. For the majority-recap comparison, read leveraged buyout acquisition financing guide.

What are the red flags to avoid?

Common growth equity partner red flags include: fund reference gaps (no follow-on rounds from LPs), management churn in prior portfolio companies, aggressive founder-replacement patterns, insistence on full participating preferred with no cap, refusal to cap consent-right thresholds, and demands for outsized management-fee reimbursement. Reference-checking three or four portfolio company CEOs is the single highest-leverage diligence step a founder can run.

The founder is diligencing the fund as much as the fund is diligencing the company. That framing is not universal but it should be. A growth equity partner will sit at the board for 4 to 7 years, will drive major strategic decisions during downturns, and will pick or approve the exit buyer. Getting that partner wrong is expensive in ways a first-time raiser rarely models.

In our experience advising LMM operators through growth equity partner selection, the highest-leverage founder diligence is a 90-minute unstructured phone call with three CEOs of prior sponsor portfolio companies, two who exited well and one who did not. Ask them what happened in the first 100 days, what happened when the plan slipped, how the fund handled a CEO or CFO transition, and how the fund behaved during exit negotiations. Founders who skip this step and rely only on the fund’s public reputation regret it within 18 months when the first difficult board meeting arrives and the fund’s true operating style becomes visible.

Concrete red flags to watch for during diligence:

• Prior CEO transitions. Look at the fund’s last 10 portfolio companies. If more than 3 of 10 had a CEO change within 24 months of investment, that pattern is directional signal.
• Add-on M&A obligations. If the sponsor requires committed add-on M&A within 12 months as a condition of closing, that is a control lever disguised as growth support.
• Board expansion clauses. Watch for automatic board seat expansions tied to future capital calls or performance triggers. These clauses can shift control without a new negotiation.
• Vague protective provisions. Consent rights should be enumerated with dollar thresholds and time limits. Broad “material actions” language gives the fund veto rights on operational decisions.
• Reimbursement of ongoing fund expenses. Some funds seek to charge management fees or monitoring fees to the portfolio company. In 2026, this practice is under regulatory scrutiny per SEC newsroom commentary on private fund adviser rules.
• Registration rights that trigger a forced IPO. Rare but exists. Founders should insist on demand rights that require reasonable notice and market conditions.
• Drag-along at year 3. Standard drag-along thresholds sit at year 5 to 7. A year-3 drag reduces the founder’s control over exit timing.

What are the 2024-2026 market dynamics?

The 2024-2026 growth equity market runs on record dry powder ($348 billion globally per Bain 2025), materially lower deal volume than 2021, and a widening gap between quality assets and average targets. Fed funds at 4.25% to 4.50% (July 2026 FOMC) keeps debt expensive and pushes LMM operators toward equity-heavy structures. Median entry multiples on LMM growth deals sat at 9.2x TTM EBITDA in 2024 per PitchBook.

Understanding the current cycle matters because it affects both timing and terms. Two forces drive the 2026 market: a large overhang of committed but undeployed capital, and a small pool of high-quality profitable LMM targets. Sponsors are patient with average deals and aggressive with premium ones.

Dry powder. Global growth equity dry powder hit a record $348 billion in 2025 per Bain and Company Global Private Equity Report 2025, up from $290 billion at the end of 2023. In the LMM segment specifically, funds like Summit Partners closed a $9B Fund XI, TA Associates closed a $16.5B Fund XV, and JMI Equity closed a $6B Fund XI, per SEC Form D filings and public press releases. The market is not capital-constrained; it is target-constrained.

Deal volume. Global growth equity deal count in 2024 came in at roughly 4,200 transactions, down 22% from the 2021 peak per PitchBook 2024 US PE Breakdown. Deal value fell more sharply as sponsors held out for cleaner assets at more reasonable multiples.

Multiples. Median LMM growth equity entry multiples ran 9.2x TTM EBITDA in 2024, down from the 11.4x 2021 peak but well above the 7.8x 2018 baseline. Vertical SaaS deals cleared higher (12x to 18x forward ARR); tech-enabled services cleared lower (7x to 10x TTM EBITDA); healthcare services ranged 8x to 11x TTM EBITDA.

Interest rate environment. The July 2026 FOMC statement pinned the federal funds target range at 4.25% to 4.50% per the Federal Reserve FOMC calendar. SOFR-plus unitranche pricing sits at 10.5% to 12.5% all-in. That keeps senior debt expensive relative to 2021 (when unitranche cleared 7% to 8%), which pushes LMM operators toward equity-heavy stacks and grows the market share of growth equity relative to leveraged buyout structures.

2024-2026 named comps. The following table lists five real 2024-2026 LMM growth equity deals with publicly-reported terms.

Target company	Sponsor	Announced	Check size	Sector
Semarchy	Providence Strategic Growth (PSG)	Q2 2024	$50M growth investment	Data management software
Health Connect America	Frontenac Company	2024 recap	Undisclosed 8-figure	Behavioral health services
Netsertive	TA Associates	Q4 2024	Undisclosed growth round	MarTech and digital advertising
RxLightning	Volition Capital (co-led)	Q1 2024	$17.5M Series B	Healthcare tech
RangeMe	Susquehanna Growth Equity	2024 investment	Undisclosed minority	B2B commerce platform

The 2026 climate favors sellers with clean data, profitable growth, and defensible sector positions. It punishes sellers with concentration risk, aggressive add-backs, or hockey-stick forecasts unsupported by trailing performance. That asymmetry is the reason process quality matters more in 2026 than in 2021, when almost any deal cleared. For 2026 debt-market context, review unitranche debt acquisition financing.

How does CT Acquisitions help you find the right growth equity partner?

CT Acquisitions runs targeted growth equity partner processes for LMM operators, curating a shortlist of 20 to 40 sponsors from the 60-fund LMM universe based on the client’s sector, check size need, dilution tolerance, and post-close role preference. CT coordinates QoE, CIM, buyer outreach, LOI negotiation, and confirmatory diligence through close. Typical process duration is 4 to 9 months with a 1% to 3% success fee.

The gap between a self-run raise and a professionally-run process shows up in three places: the number of bids received, the terms in the winning LOI, and the closing certainty. In a 2024 review of 30 LMM growth equity processes, Axial 2024 process research found that advisor-run auctions produced a median of 8 written IOIs vs 2 for self-run inbound; the advisor-run auctions cleared at 15% to 25% higher enterprise value; and 88% closed vs 61% for self-run.

CT Acquisitions specifically brings four capabilities to a growth equity partner search:

1. Sponsor curation and shortlisting. Not every growth equity fund fits every operator. CT screens the LMM universe by check size, sector fit, control preference, follow-on capital availability, and cultural style. The shortlist runs 20 to 40 sponsors, not the full 400+ private capital firms in the market.
2. Process management. Advisor drives the CIM, coordinates the QoE provider, runs the buyer outreach, hosts management meetings, and manages the LOI negotiation. Founder stays focused on running the business through the entire 4 to 9 month process.
3. Term sheet negotiation. CT has negotiated hundreds of preferred-stock term sheets across sectors and check sizes. Common negotiation wins for our clients include converting participating preferred to non-participating, tightening consent-right thresholds, capping fund fee reimbursement, and structuring founder rollover for optimal tax treatment.
4. Post-LOI defense. The LOI is the halfway mark, not the finish line. Confirmatory diligence typically produces one to three purchase price adjustment requests. CT defends the LOI valuation through diligence and manages the QoE bridge to protect the founder’s economics.

For a full pillar view of CT’s advisor services, see m-and-a-advisory, buy-side m-and-a-advisory, and the lower middle market M&A advisor deep-dive.

How do you choose among competing advisors?

Choosing an M&A advisor for a growth equity partner raise depends on five factors: sector expertise, deal-size fit, sponsor relationship depth, process discipline, and cultural match. LMM operators typically interview 3 to 5 advisors, check 2 to 3 references per finalist, and select on a combination of sponsor rolodex and process track record. Bulge-bracket banks (Goldman, Morgan Stanley) rarely fit LMM economics; boutique advisors and specialized placement agents typically outperform on fee structure and process attention.

The advisor selection decision often surprises first-time raisers. The most-famous investment banks are usually the wrong choice for an LMM growth equity round because their fee minimums (often $2M to $5M) exceed 5% to 8% of a $30M raise. Bulge-bracket coverage is thin below $100M in enterprise value, and the junior banker doing the actual work often lacks LMM-specific experience.

The following comparison shows the four main advisor categories that compete for LMM growth equity mandates.

Advisor type	Typical fee	Deal size sweet spot	Strengths	Weaknesses
Bulge-bracket IB (Goldman, MS, JPM)	$3M+ minimum or 1% success	$500M+ enterprise value	Sponsor rolodex, brand pull	Expensive, thin LMM attention
Middle-market IB (Houlihan Lokey, Raymond James, William Blair)	1% to 2.5% success	$50M to $500M EV	Balanced coverage, sector teams	Fee minimums for sub-$50M deals
Boutique advisor (specialized)	1.5% to 3% success + retainer	$10M to $150M EV	Senior attention, sector depth	Smaller sponsor rolodex
Placement agent (equity-only)	3% to 5% of capital raised	$5M to $75M raise	Deep sponsor relationships	Narrow to equity-only mandate

For a $10M to $50M LMM growth equity raise, boutique advisors and placement agents typically outperform larger banks on both process attention and total cost. For a $50M to $150M raise, middle-market IBs and specialized boutiques compete effectively. Above $150M, middle-market and bulge-bracket banks dominate. According to McKinsey Global Private Markets Report 2025, boutique and mid-market advisors captured a growing share of LMM growth equity mandates through 2024 as clients prioritized senior attention over brand.

Reference-checking is the highest-leverage step in advisor selection. Ask each finalist for three prior LMM growth equity clients, and call them. Ask about process discipline, seniority of attention, LOI negotiation quality, and diligence defense. Ninety minutes of reference calls prevents most advisor-selection mistakes.

Frequently asked questions

What is a growth equity partner?

A growth equity partner is a minority institutional investor that puts $10M to $150M of primary or secondary capital into a profitable, scaling lower middle market company in exchange for 15% to 45% ownership, a board seat, protective consent rights, and a preferred-return structure. Unlike venture capital, growth equity requires proven unit economics, positive EBITDA, and a specific use of proceeds tied to a defensible expansion thesis.

How much equity do I give up to a growth equity partner?

Median 2025 LMM growth equity minority rounds cleared at a 27% stake sold per GF Data, with a range of 15% to 45% depending on check size relative to enterprise value. A $20M primary check into a $60M enterprise-value business would typically dilute the founder by 25% to 33%, with the remainder held as convertible preferred with a 1x non-participating liquidation preference.

How is growth equity different from venture capital?

Growth equity backs profitable, revenue-generating companies with proven product-market fit; venture capital funds pre-revenue or pre-profit startups. Growth equity checks range from $10M to $150M against $5M+ ARR or $1M+ EBITDA, priced on trailing or forward earnings. Venture rounds price on projected growth curves and future ARR, often with no current profitability. The dilution, coupon, and control terms are also materially different.

How long does a growth equity raise take?

A well-run growth equity partner process closes in 4 to 9 months from CIM launch, per typical LMM auction timelines. QoE preparation takes 6 to 10 weeks, marketing runs 4 to 6 weeks, IOIs come in at week 6, management meetings run 4 to 8 weeks, LOI executes at week 12 to 16, and confirmatory diligence plus documentation adds another 8 to 14 weeks before closing.

What are the top named growth equity firms in 2026?

Named LMM-focused growth equity firms with active 2026 mandates include Summit Partners ($9B latest fund per SEC filings), TA Associates, Great Hill Partners, Spectrum Equity, Susquehanna Growth Equity, JMI Equity ($6B Fund XI per PitchBook 2024), Mainsail Partners, Frontenac, Volition Capital, and Providence Strategic Growth. Sector focus varies from software (JMI, Mainsail) to healthcare (Frontenac) to consumer (Great Hill).

Do I need an M&A advisor to raise growth equity?

Not legally, but a competent M&A advisor typically produces 6 to 12 written bids versus 1 to 3 in a self-run process and closes the auction spread at 15% to 25% higher enterprise value per Axial 2024 process data. For LMM rounds under $50M, boutique advisors and specialized placement agents outperform bulge-bracket investment banks on both fees and process discipline.

What is a typical growth equity term sheet structure?

A 2026 growth equity term sheet would typically feature convertible preferred stock, 1x non-participating liquidation preference (or 1x participating with 3x cap), 6% to 8% cumulative preferred coupon, weighted-average anti-dilution, protective consent rights on major decisions, one board seat with observer rights, drag-along and tag-along, and management rollover of 20% to 50% of prior equity.

Can I get liquidity from a growth equity partner?

Yes. Most growth equity rounds combine primary capital (into the balance sheet for growth) with secondary capital (to the founder). A common 2025 structure is a $30M total check split $20M primary and $10M secondary, letting the founder take chips off the table while keeping majority control. Some funds cap secondary at 20% to 30% of the check to keep management aligned.

Related reading

• Raise Capital pillar hub
• Growth equity vs private equity
• Selling to a growth equity investor
• Family office vs PE buyer
• Mezzanine debt for acquisitions guide
• Unitranche debt acquisition financing
• Leveraged buyout acquisition financing guide
• What is a term sheet
• Lower middle market M&A advisor
• M&A advisory (sell-side pillar)
• Buy-side M&A advisory
• Business acquisition loan